blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3993806

EP3993806 - THIARABINE- AND THIARABINE PRODRUG-BASED TREATMENTS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  08.04.2022
Database last updated on 11.09.2024
FormerThe international publication has been made
Status updated on  11.12.2020
Most recent event   Tooltip28.05.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Southern Research Institute
2000 9th Avenue South
Birmingham, Alabama 35205 / US
[2022/19]
Inventor(s)01 / MOUKHA-CHAFIQ, Omar
5862 Water Branch Rd.
Hoover, AL 35244 / US
02 / SUTO, Mark J.
402 Devon Drive
Homewood, AL 35209 / US
03 / LIU, Jie
4254 Hamlin Place
Vestavia, AL 35242 / US
04 / BOOHAKER, Rebecca
2501 Oneal Circle
Birmingham, AL 35226 / US
05 / AUGELLI-SZAFRAN, Corinne E.
Homewood, AL 35209 / US
 [2022/39]
Former [2022/19]01 / MOUKHA-CHAFIQ, Omar
5862 Water Branch Rd.
Hoover, AL 35244 / US
02 / SUTO, Mark J.
402 Devon Drive
Homewood, AL 35209 / US
03 / LIU, Jie
4254 Hamlin Place
Vestavia, AL 35242 / US
04 / BOOHAKER, Rebecca
2501 Oneal Circle
Birmingham, AL 35226 / US
Representative(s)CH Kilger Anwaltspartnerschaft mbB
Fasanenstraße 29
10719 Berlin / DE
[2022/19]
Application number, filing date20817916.804.06.2020
[2022/19]
WO2020US36125
Priority number, dateUS201962857686P05.06.2019         Original published format: US 201962857686 P
[2022/19]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020247633
Date:10.12.2020
Language:EN
[2020/50]
Type: A1 Application with search report 
No.:EP3993806
Date:11.05.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 10.12.2020 takes the place of the publication of the European patent application.
[2022/19]
Search report(s)International search report - published on:US10.12.2020
(Supplementary) European search report - dispatched on:EP11.08.2023
ClassificationIPC:A61K31/5415, A61K31/7068, A61P35/00, A61K31/708, A61K31/7076
[2023/37]
CPC:
C07K16/2818 (EP,IL,KR); A61K31/7068 (EP,IL,KR,US); A61K31/7076 (EP,IL,KR);
A61K31/708 (EP,IL,KR); A61K39/3955 (EP,IL,KR,US); A61P35/00 (EP,KR,US);
A61K2300/00 (IL,KR); C07K2317/24 (EP,IL,KR); C07K2317/76 (EP,IL,KR) (-)
C-Set:
A61K31/7068, A61K2300/00 (EP);
A61K31/7076, A61K2300/00 (EP);
A61K31/708, A61K2300/00 (EP);
A61K39/3955, A61K2300/00 (EP)
Former IPC [2022/19]A61K31/5415, A61K31/7068
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/19]
TitleGerman:AUF THIARABIN UND THIARABINPRODRUG BASIERENDE BEHANDLUNGEN[2022/19]
English:THIARABINE- AND THIARABINE PRODRUG-BASED TREATMENTS[2022/19]
French:TRAITEMENTS À BASE DE PROMÉDICAMENT DE THIARABINE ET DE THIARABINE[2022/19]
Entry into regional phase03.01.2022National basic fee paid 
06.01.2022Search fee paid 
06.01.2022Designation fee(s) paid 
06.01.2022Examination fee paid 
Examination proceduredeletedDeletion: Application deemed to be withdrawn, date of legal effect  [2022/19]
06.01.2022Examination requested  [2022/19]
22.03.2022Despatch of communication that the application is deemed to be withdrawn, reason: filing fee / search fee not paid in time  [2022/19]
01.03.2024Amendment by applicant (claims and/or description)
01.03.2024Date on which the examining division has become responsible
Request for further processing for:The application is deemed to be withdrawn due to non-payment of designation fees
HR, CH, IT, TR, SM, SK, SI, SE, RS, RO, PT, PL, NO, NL, MT, MK, MC, LV, LU, LT, IS, IE, HU, GR, GB, FR, FI, ES, EE, DK, DE, CZ, CY, BG, BE, AT, AL
31.03.2022Request for further processing filed
31.03.2022Full payment received (date of receipt of payment)
Request granted
11.04.2022Decision despatched
The application is deemed to be withdrawn due to non-payment of the search fee
31.03.2022Request for further processing filed
31.03.2022Full payment received (date of receipt of payment)
Request granted
11.04.2022Decision despatched
31.03.2022Request for further processing filed
31.03.2022Full payment received (date of receipt of payment)
Request granted
11.04.2022Decision despatched
The application is deemed to be withdrawn due to non-payment of the examination fee
31.03.2022Request for further processing filed
31.03.2022Full payment received (date of receipt of payment)
Request granted
11.04.2022Decision despatched
Fees paidRenewal fee
06.01.2022Renewal fee patent year 03
08.05.2023Renewal fee patent year 04
27.05.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]EP1100512  (SOUTHERN RES INST [US]) [Y] 1-11,13 * example -; claim - *;
 [Y]  - DAS SATYA ET AL, "Promising New Agents for Colorectal Cancer", CURRENT TREATMENT OPTIONS IN ONCOLOGY, SPRINGER US, NEW YORK, vol. 19, no. 6, doi:10.1007/S11864-018-0543-Z, ISSN 1527-2729, (20180511), pages 1 - 14, (20180511), XP036515735 [Y] 1-11,13 * the whole document *

DOI:   http://dx.doi.org/10.1007/s11864-018-0543-z
 [Y]  - YOSHIMURA Y ET AL, "A facile alternative synthesis of 4-'Thioarabinonucleosides and Their Biological Activities", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, (19970101), vol. 40, doi:10.1021/JM9701536, ISSN 0022-2623, pages 2177 - 2183, XP002174619 [Y] 1-11,13 * whole document, in particular table 2 and scheme 3 (compound 6h) *

DOI:   http://dx.doi.org/10.1021/jm9701536
International search[A]US2005256143  (JEONG LAK S [KR], et al) [A] 5 * ; Abstract p8 *;
 [A]US2010237108  (ANDERSON JAMES [GB], et al) [A] 1-20 * ; entire document *;
 [A]US2010324277  (BHAT BALKRISHEN [US], et al) [A] 1-20 * ; entire document *;
 [Y]US2016176962  (MURRIEL CHRISTOPHER LAMOND [US], et al) [Y] 13-14, 19 * ; para[0315] *;
 [A]US2017029456  (DOUSSON CYRIL B [FR], et al) [A] 1-20 * ; entire document *;
 [XYA]US2018208621  (DOUSSON CYRIL B [FR], et al) [X] 1-4, 6-12, 15-18, 20 * ; para[0012] para[0091] para[0138] para[0324] para[0332] * [Y] 13-14, 19 [A] 5;
 [PA]WO2019204637  (SOUTHERN RES INST [US]) [P] 1-20 * ; entire document *[A] 0;
 [A]  - "4-Amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5- (hydroxymethyl)thiolan-2-yl]-1,3,5-triazin-2-one", Pubmed Compound, (20061025), Database accession no. CID 9903306, URL: ncbi, XP055768178 [A] 5 * ; p2 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.